Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Accro Bioscience logo

Accro Bioscience

Recent Finacing

Series C

Recent Raise

$50M

Accro Bioscience is a clinical-stage biotechnology company developing novel therapeutics that target molecular mechanisms of regulatory cell death for inflammatory and autoimmune diseases.

Founded 2016
Jiangsu, China
11-50
Private
accro.com.cn
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology

Recent Investors

Shenzhen Capital Group logo
Lilly Asia Ventures logo
TCGX logo
OrbiMed logo
Oriza Ventures logo
Cenova Capital logo
元禾控股 logo
洪泰基金 logo
中南创投基金 logo
Leader Ventures logo
合肥创新投 logo
Morningside Ventures logo

Financials

$112M

Total Raised

3

Funding rounds

7

Investors